Search
Searching Content indexed under Patent by Kramer Levin Naftalis & Frankel LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Contracting Away The Risk Of IPR Challenges By Patent Licenses
A recent decision by the Federal Circuit confirmed the ability of patent licensors to use forum-selection clauses to have licensees contractually waive
United States
18 Jun 2019
3
Inter Partes Review Is Here To Stay In Modified Form
In a previous post here, we described constitutional and procedural challenges to inter partes review ("IPR") in the Oil States and SAS Institute cases taken up by the U.S. Supreme Court.
United States
23 Aug 2018
4
Preserving Provisional Rights For Pre-Issuance Patent Damages
Intellectual Property partner Brian V. Slater and associate John P. Dillon's article "Preserving Provisional Rights for Pre-Issuance Patent Damages" ran in the January/February 2018 issue of Landslide, published by the American Bar Association.
United States
21 Feb 2018
5
The Future of Inter Partes Review in the Balance
Three pending cases have the potential to reshape – or even eliminate – inter partes review, a procedure for challenging patent validity introduced by the 2011 America Invents Act ("AIA").
United States
29 Nov 2017
6
Do American Indian Tribal Deals Shield Patent Owners From Inter Partes Review?
Intellectual Property partner Brian V. Slater authored an article titled "Do American Indian Tribal Deals Shield Patent Owners from Inter Partes Review?" which appeared in the Kluwer Patent Blog on Nov. 1, 2017.
United States
22 Nov 2017
7
Deep Dive: Does The PTO's Inter Partes Review Violate The Constitution?
"Deep Dive: Does the PTO's Inter Partes Review Violate the Constitution?," an article by Intellectual Property partner Mark A. Baghdassarian, and associates John P. Dillon and Matthew W. Olinzock...
United States
19 Sep 2017
8
BPCIA Questions Continue To Arise For Biosimilar Applicants
Intellectual Property partner Gregory B. Sephton, special counsel Christine Willgoos and associate John P. Dillon's article "BPCIA Questions Continue To Arise For Biosimilar Applicants"...
United States
17 Aug 2017
9
Supreme Court Issues Highly Anticipated Decision Interpreting The Biologics Price Competition And Innovation Act
On June 12, the Supreme Court decided Sandoz Inc. v. Amgen Inc., the first case under the Biologics Price Competition and Innovation Act of 2009 (BPCIA) to reach the high court.
United States
4 Jul 2017
10
Potential Impact Of The Supreme Court's Decision To Review The PTAB's Practice Of Issuing Partial Final Written Decisions In Post-Grant Proceedings
In a case with potential wide-ranging ramifications for patent validity challenges, on May 22, 2017, the Supreme Court granted a writ of certiorari in an appeal from an IPR decision...
United States
13 Jun 2017
11
Scotus Expands The Doctrine Of Patent Exhaustion To Sales Outside The US And Confirms That The Doctrine Cannot Be Limited Through Post-Sale Restrictions
This alert examines the Supreme Court's Impression Products decision, which expands the doctrine of patent exhaustion to sales outside the U.S. and confirms that the doctrine cannot be limited...
United States
2 Jun 2017
12
Potential Impact of the Supreme Court's Decision to Review the PTAB's Practice of Issuing Partial Final Written Decisions in Post-Grant Proceedings
This alert examines the potential impact of the Supreme Court's decision to review the PTAB's practice of issuing partial final written decisions in post-grant proceedings.
United States
1 Jun 2017
13
Supreme Court To Consider Biologics Price Competition And Innovation Act
This alert examines the Supreme Court's granting of the appellant's petition and the respondent's cross-petition for a writ of certiorari in Sandoz Inc. v. Amgen Inc.
United States
19 Jan 2017
14
Recent Changes In U.S. Patent Law
The article examines the early strategic decisions required by German companies interested in selling their products in the U.S. market.
United States
25 Oct 2016
15
Innovation Financing, Finance And Innovation(s)
Paris partner Hubert de Vauplane's article, "Innovation Financing, Finance and Innovation(s)," appeared in the Sept. 15, 2016 issue of the French legal publication JCPE n°37.
United States
21 Sep 2016
16
Federal Circuit Preserves Plaintiff's Choice Of Forum In Hatch-Waxman Cases
Intellectual Property special counsel Christine Willgoos and associate Shannon H. Hedvat's article "Federal Circuit Preserves Plaintiff's Choice of Forum in Hatch-Waxman Cases," appeared in the May/June 2016 issue of IP Litigator.
United States
22 Jul 2016
17
Supreme Court Denies Certiorari In Sequenom v. Ariosa
The Supreme Court denies certiorari in Sequenom v. Ariosa, leaving undisturbed the invalidation of a genetic testing patent under Section 101.
United States
29 Jun 2016
18
Federal Circuit Preserves Plaintiff's Choice Of Forum In Hatch-Waxman Cases
On March 18, 2016, the Federal Circuit decided Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc. and held that future sales by a generic defendant of the patented product at issue is a basis for specific jurisdiction over the defendant.
United States
13 Apr 2016
Links to Result pages
 
1